U.S. OK's Thermo Fisher buy of Life Tech; must sell assets
WASHINGTON (Reuters) - Thermo Fisher Scientific Inc (TMO.N), the world's largest laboratory equipment maker, has won U.S. antitrust approval to buy California's Life Technologies Corp LIFE.O on the condition that some assets are sold, the Federal Trade Commission said on Friday.
The deal was valued at $13.6 billion when it was announced in April.
The commission said the companies agreed to sell a Thermo Fisher business, based in Massachusetts, that makes siRNA reagents used to study gene function. It must also sell businesses that make cell culture media like salts and sugars, and cell culture sera, derived from animal blood and used to grow mammalian cells.
GH Health will purchase the divested businesses, the FTC said.
The deal previously received antitrust approval from China and the European Union.
HELSINKI - Finnish start-up Next Games has raised $6 million in funding in the latest of several venture capital investments in the Nordic country's booming mobile games industry, the company said on Wednesday.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.